Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Loss-of-function mutations in APOC3, triglycerides, and coronary disease

  • Jacy Crosby
  • , Gina M. Peloso
  • , Paul L. Auer
  • , David R. Crosslin
  • , Nathan O. Stitziel
  • , Leslie A. Lange
  • , Yingchang Lu
  • , Zheng Zheng Tang
  • , He Zhang
  • , George Hindy
  • , Nicholas Masca
  • , Kathleen Stirrups
  • , Stavroula Kanoni
  • , Ron Do
  • , Goo Jun
  • , Youna Hu
  • , Hyun Min Kang
  • , Chenyi Xue
  • , Anuj Goel
  • , Martin Farrall
  • Stefano Duga, Pier Angelica Merlini, Rosanna Asselta, Domenico Girelli, Oliviero Olivieri, Nicola Martinelli, Wu Yin, Dermot Reilly, Elizabeth Speliotes, Caroline S. Fox, Kristian Hveem, Oddgeir L. Holmen, Majid Nikpay, Deborah N. Farlow, Themistocles L. Assimes, Nora Franceschini, Jennifer Robinson, Kari E. North, Lisa W. Martin, Mark DePristo, Namrata Gupta, Stefan A. Escher, Jan Håkan Jansson, Natalie Van Zuydam, Colin N.A. Palmer, Nicholas Wareham, Werner Koch, Thomas Meitinger, Annette Peters, Wolfgang Lieb, Raimund Erbel, Inke R. Konig, Jochen Kruppa, Franziska Degenhardt, Omri Gottesman, Erwin P. Bottinger, Christopher J. O'Donnell, Bruce M. Psaty, Christie M. Ballantyne, Goncalo Abecasis, Jose M. Ordovas, Olle Melander, Hugh Watkins, Marju Orho-Melander, Diego Ardissino, Ruth J.F. Loos, Ruth McPherson, Cristen J. Willer, Jeanette Erdmann, Alistair S. Hall, Nilesh J. Samani, Panos Deloukas, Heribert Schunkert, James G. Wilson, Charles Kooperberg, Stephen S. Rich, Russell P. Tracy, Dan Yu Lin, David Altshuler, Stacey Gabriel, Deborah A. Nickerson, Gail P. Jarvik, L. Adrienne Cupples, Alex P. Reiner, Eric Boerwinkle, Sekar Kathiresan*
*Korrespondierende/r Autor/-in für diese Arbeit
  • Baylor College of Medicine
  • University of Texas Graduate School of Biomedical Sciences at Houston
  • Human Genetics Center
  • Center for Human Genetic Research
  • Harvard University
  • Broad Institute
  • University of Wisconsin-Madison
  • University of Washington, Seattle
  • Department of Medicine (Medical Genetics)
  • Washington University in St. Louis
  • University of North Carolina
  • Charles Bronfman Institute for Personalized Medicine
  • Mount Sinai School of Medicine
  • University of Michigan
  • Department of Computational Medicine and Bioinformatics
  • Universität Lund
  • University of Leicester
  • Queen Mary University of London
  • Nuffield Department of Medicine
  • Wellcome Trust Centre for Human Genetics
  • Dipartimento di Biotecnologie Mediche e Medicina Traslazionale
  • University of Milan
  • Division of Cardiology
  • Niguarda Hospital
  • University of Verona
  • Merck Sharp and Dohme
  • Division of Gastroenterology
  • NHLBI's Framingham Heart Study
  • Center for Population Studies
  • Nord-Trøndelag Health Trust
  • The Hospital of Levanger
  • Trondheim University Hospital
  • University of Ottawa
  • Stanford University
  • Departments of Epidemiology and Medicine
  • University of Iowa
  • Carolina Center for Genome Sciences
  • Skellefteå Hospital
  • Department of Public Health and Clinical Medicine
  • Umeå University
  • Medical Research Institute
  • University of Dundee
  • Addenbrooke's Hospital
  • Technische Universität München
  • Medizinische Klinik
  • Charite - Universitatsmedizin Berlin
  • Institute of Human Genetics
  • Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
  • West German Heart Center
  • Rheinische Friedrich-Wilhelms-Universität Bonn
  • Group Health Cooperative
  • Tufts University
  • Instituto Madrileño de Estudios Avanzados-Alimentacion
  • University of Parma
  • Mindich Child Health Development Institute
  • Division of Epidemiology
  • University of Leeds
  • Wellcome Sanger Institute
  • King Abdulaziz University
  • Department of Physiology and Biophysics
  • University of Mississippi
  • Public Health Sciences Division
  • Fred Hutchinson Cancer Research Center
  • University of Virginia
  • Departments of Pathology and Biochemistry
  • University of Vermont College of Medicine
  • Boston University School of Medicine

Abstract

BACKGROUND: Plasma triglyceride levels are heritable and are correlated with the risk of coronary heart disease. Sequencing of the protein-coding regions of the human genome (the exome) has the potential to identify rare mutations that have a large effect on phenotype. METHODS: We sequenced the protein-coding regions of 18,666 genes in each of 3734 participants of European or African ancestry in the Exome Sequencing Project. We conducted tests to determine whether rare mutations in coding sequence, individually or in aggregate within a gene, were associated with plasma triglyceride levels. For mutations associated with triglyceride levels, we subsequently evaluated their association with the risk of coronary heart disease in 110,970 persons. RESULTS: An aggregate of rare mutations in the gene encoding apolipoprotein C3 (APOC3) was associated with lower plasma triglyceride levels. Among the four mutations that drove this result, three were loss-of-function mutations: a nonsense mutation (R19X) and two splice-site mutations (IVS2+1G→A and IVS3+1G→T). The fourth was a missense mutation (A43T). Approximately 1 in 150 persons in the study was a heterozygous carrier of at least one of these four mutations. Triglyceride levels in the carriers were 39% lower than levels in noncarriers (P<1×10-20), and circulating levels of APOC3 in carriers were 46% lower than levels in noncarriers (P=8×10 -10). The risk of coronary heart disease among 498 carriers of any rare APOC3 mutation was 40% lower than the risk among 110,472 noncarriers (odds ratio, 0.60; 95% confidence interval, 0.47 to 0.75; P=4×10-6). CONCLUSIONS: Rare mutations that disrupt APOC3 function were associated with lower levels of plasma triglycerides and APOC3. Carriers of these mutations were found to have a reduced risk of coronary heart disease.
OriginalspracheEnglisch
ZeitschriftNew England Journal of Medicine
Jahrgang371
Ausgabenummer1
Seiten (von - bis)22-31
Seitenumfang10
ISSN0028-4793
DOIs
PublikationsstatusVeröffentlicht - 01.01.2014

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gesundheit und Wohlergehen
    SDG 3 – Gesundheit und Wohlergehen
  2. SDG 5 – Gender Equality
    SDG 5 – Gender Equality

Fingerprint

Untersuchen Sie die Forschungsthemen von „Loss-of-function mutations in APOC3, triglycerides, and coronary disease“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren